Activation of (kappa) opioid receptors produces many effects, including analgesia, dysphoria and water diuresis and kappa agonists may be useful as analgesics, water diuretics and antipruritic drugs. Kappa opioid receptors are coupled through pertussis toxin-sensitive G proteins to affect a variety of effectors. Repeated or continuous administration of Kappa agonists leads to tolerance and dependence. Part of tolerance can be accounted for at the receptor level. The applicant's long term objectives are to understand at the molecular level the biochemical events that occur following chronic exposure to opioid drugs. After exposure to the selective agonist U50, 488H, the human kappa opioid receptor (hkor) undergoes internalization and the internalized receptors are recycled to plasma membranes or sorted to lysosomes and proteasomes for degradation. Whether there are signals directing the sorting of the internalized receptors is not well understood. The central hypothesis of this application is that the hkor is associated with EBP50/NHERF-1 and GABARAPL1 and undergoes ubiquitination, all of which play important roles in the regulation, trafficking and signaling of the receptor.
The specific aims are as follows. (1) To investigate the interaction of the hkor with EBP50/NHERF-1, a PDZ domain-containing protein. The residues in the hkor involved in the interaction with EBP50/NHERF-1 will be determined by mutagenesis studies. Effects of receptor phosphorylation and ubiquitination on its association with EBP50/NHERF-1 will be assessed and the role of EBP50/NHERF in the U50,488H-induced stimulation of Na+,H+-exchange will be examined. (2) To examine the interaction of the hkor with GABARAPL 1. Whether there are interactions between GABARAPL1 and tubulin, N-ethylmaleimide-sensitive factor, EBP50/NHERF-1, rab5 or rab7 will be investigated. The regions of GABARAPL 1 and the hkor involved in the interaction will be determined. The functional significance of the hkor-GABARAPL1 interaction will be studied in terms of trafficking, surface expression, ligand binding and signal transduction of the hkor. (3) To delineate the role of ubiquitination in the signaling and trafficking of the hkor. Effects of different agonists and receptor phosphorylation on ubiquitination of the hkor will be examined. The sites of ubiquitination in the hkor will be determined by mutagenesis. The impact of ubiquitination on the functional properties, regulation and trafficking of the hkor will be investigated. Elucidation of the functional significance of EBP50/NHERF-1 and GABARAPL 1 and receptor ubiquitination in the trafficking and signaling of the hkor will provide better understanding of cell biology of the hkor and will have implications for development of kappa agonists and antagonists as therapeutic agents. In addition, such understanding will have important ramifications for other G protein coupled receptors since these molecules may play similar roles for other receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA017302-01
Application #
6709811
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Lin, Geraline
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
1
Fiscal Year
2004
Total Cost
$358,575
Indirect Cost
Name
Temple University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Chen, Chongguang; Chiu, Yi-Ting; Wu, Wenman et al. (2016) Determination of sites of U50,488H-promoted phosphorylation of the mouse ? opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization. Biochem J 473:497-508
Huang, Peng; Yakovleva, Tatyana; Aldrich, Jane V et al. (2016) Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests. Neurosci Lett 615:15-20
Chen, Chongguang; Huang, Peng; Liu-Chen, Lee-Yuan (2015) Identification and verification of proteins interacting with the kappa opioid receptor (KOPR). Methods Mol Biol 1230:129-40
Huang, Peng; Chen, Chongguang; Liu-Chen, Lee-Yuan (2015) Detection of mu opioid receptor (MOPR) and its glycosylation in rat and mouse brains by western blot with anti-?C, an affinity-purified polyclonal anti-MOPR antibody. Methods Mol Biol 1230:141-54
DiMattio, Kelly M; Ehlert, Frederick J; Liu-Chen, Lee-Yuan (2015) Intrinsic relative activities of ? opioid agonists in activating G? proteins and internalizing receptor: Differences between human and mouse receptors. Eur J Pharmacol 761:235-44
DiMattio, Kelly M; Chen, Chongguang; Shi, Lei et al. (2015) K303?ยท?? in the ? opioid (MOP) receptor is important in conferring selectivity for covalent binding of ?-funaltrexamine (?-FNA). Eur J Pharmacol 748:93-100
Wang, Yu-Jun; Huang, Peng; Blendy, Julie A et al. (2014) Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTP?S binding in mice with Oprm1 A112G. Addict Biol 19:354-61
Dimattio, K M; Yakovleva, T V; Aldrich, J V et al. (2014) Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neurosci Lett 563:155-9
Van't Veer, Ashlee; Bechtholt, Anita J; Onvani, Sara et al. (2013) Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology 38:1585-97
Xu, Wei; Wang, Yujun; Ma, Zhongze et al. (2013) L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors. Drug Alcohol Depend 133:693-703

Showing the most recent 10 out of 58 publications